110.04
price down icon8.92%   -10.78
after-market アフターアワーズ: 112.09 2.05 +1.86%
loading
前日終値:
$120.82
開ける:
$116.48
24時間の取引高:
2.17M
Relative Volume:
2.41
時価総額:
$6.68B
収益:
$3.99B
当期純損益:
$463.16M
株価収益率:
15.50
EPS:
7.1
ネットキャッシュフロー:
$1.10B
1週間 パフォーマンス:
-10.48%
1か月 パフォーマンス:
-20.81%
6か月 パフォーマンス:
+0.60%
1年 パフォーマンス:
-4.49%
1日の値動き範囲:
Value
$109.76
$117.11
1週間の範囲:
Value
$109.76
$127.87
52週間の値動き範囲:
Value
$99.06
$148.06

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
名前
Jazz Pharmaceuticals Plc
Name
セクター
Healthcare (1162)
Name
電話
353-1-634-7800
Name
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
職員
2,800
Name
Twitter
@jazzpharma
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
JAZZ's Discussions on Twitter

JAZZ を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
JAZZ
Jazz Pharmaceuticals Plc
110.04 6.68B 3.99B 463.16M 1.10B 7.10
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-07 アップグレード UBS Neutral → Buy
2025-02-26 ダウングレード Cantor Fitzgerald Overweight → Neutral
2025-02-13 アップグレード Wells Fargo Equal Weight → Overweight
2024-12-12 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-06-05 開始されました Goldman Buy
2024-01-03 開始されました Robert W. Baird Outperform
2023-11-27 ダウングレード UBS Buy → Neutral
2023-09-29 開始されました Raymond James Mkt Perform
2023-06-12 再開されました Wells Fargo Equal Weight
2022-12-09 アップグレード Goldman Neutral → Buy
2022-06-14 開始されました UBS Buy
2022-04-06 ダウングレード Goldman Buy → Neutral
2021-11-19 再開されました Goldman Buy
2021-10-07 再開されました Jefferies Buy
2021-10-05 開始されました Citigroup Buy
2021-09-23 開始されました Needham Buy
2021-05-19 再開されました JP Morgan Overweight
2021-04-07 再開されました RBC Capital Mkts Outperform
2021-02-05 繰り返されました H.C. Wainwright Buy
2021-02-03 アップグレード Piper Sandler Neutral → Overweight
2021-01-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-16 開始されました UBS Buy
2020-11-03 繰り返されました H.C. Wainwright Buy
2020-10-09 繰り返されました H.C. Wainwright Buy
2020-09-14 ダウングレード Goldman Neutral → Sell
2020-09-14 再開されました JP Morgan Overweight
2020-08-06 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-28 アップグレード Wolfe Research Peer Perform → Outperform
2020-07-23 アップグレード H.C. Wainwright Neutral → Buy
2020-04-06 開始されました Jefferies Buy
2020-03-12 アップグレード Bernstein Mkt Perform → Outperform
2020-01-08 開始されました Goldman Neutral
2019-08-21 ダウングレード Piper Jaffray Overweight → Neutral
2019-06-11 開始されました Barclays Overweight
2019-03-20 開始されました SunTrust Buy
2018-12-14 開始されました Wolfe Research Peer Perform
2018-11-08 繰り返されました B. Riley FBR Buy
2018-08-08 繰り返されました Stifel Buy
2018-07-11 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-03-23 繰り返されました H.C. Wainwright Neutral
2018-03-19 アップグレード Morgan Stanley Equal-Weight → Overweight
すべてを表示

Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース

pulisher
Apr 04, 2025

Potential Tariffs Pose Challenges for Jazz Pharmaceuticals (JAZZ) - GuruFocus

Apr 04, 2025
pulisher
Apr 03, 2025

RBC Raises Price Target on Jazz Pharmaceuticals to $182 From $178, Keeps Outperform Rating - MarketScreener

Apr 03, 2025
pulisher
Apr 02, 2025

Post-traumatic Stress Disorder Treatment Market Generated - openPR.com

Apr 02, 2025
pulisher
Apr 01, 2025

After a year of 4.3% returns, Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) share price drop last week may have less of an impact on institutional investors - Yahoo Finance

Apr 01, 2025
pulisher
Mar 31, 2025

JAZZ or ARGX: Which Is the Better Value Stock Right Now? - Yahoo Finance

Mar 31, 2025
pulisher
Mar 30, 2025

Teacher Retirement System of Texas Buys 2,346 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Mar 30, 2025
pulisher
Mar 29, 2025

Is Jazz Pharmaceuticals (JAZZ) the Best Mid Cap Biotech Stock to Buy? - Insider Monkey

Mar 29, 2025
pulisher
Mar 27, 2025

Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Mar 27, 2025
pulisher
Mar 26, 2025

10 Best Mid Cap Biotech Stocks to Buy - Insider Monkey

Mar 26, 2025
pulisher
Mar 26, 2025

Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - Eagle-Tribune

Mar 26, 2025
pulisher
Mar 26, 2025

Dravet Syndrome Market Expected to Experience Major Growth - openPR

Mar 26, 2025
pulisher
Mar 26, 2025

Jazz Pharma Reveals Growth Strategy: Key Updates Coming at Major Healthcare Conference - Stock Titan

Mar 26, 2025
pulisher
Mar 25, 2025

Is Jazz Pharmaceuticals plc (JAZZ) a Promising Biotech Stock According to Wall Street Analysts - Insider Monkey

Mar 25, 2025
pulisher
Mar 25, 2025

Focal Epilepsy Market: Analysis of Epidemiology, Pipeline - openPR

Mar 25, 2025
pulisher
Mar 25, 2025

Axsome's ADHD drug meets main goal in late-stage study - Marketscreener.com

Mar 25, 2025
pulisher
Mar 24, 2025

12 Most Promising Biotech Stocks According to Wall Street Analysts - Insider Monkey

Mar 24, 2025
pulisher
Mar 24, 2025

Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Mar 24, 2025
pulisher
Mar 24, 2025

Jazz strikes the chord with $935m Chimerix acquisition - Xconomy

Mar 24, 2025
pulisher
Mar 24, 2025

Based On Its ROE, Is Jazz Pharmaceuticals plc (NASDAQ:JAZZ) A High Quality Stock? - simplywall.st

Mar 24, 2025
pulisher
Mar 24, 2025

Zacks.com featured highlights include MPLX LP, Leidos, Jazz Pharmaceuticals, Fortinet and Pilgrim's Pride - Yahoo Finance

Mar 24, 2025
pulisher
Mar 21, 2025

Chimerix Reports Fourth Quarter and Year End 2024 Financial Results - GlobeNewswire Inc.

Mar 21, 2025
pulisher
Mar 20, 2025

Akari Therapeutics Appoints Biotechnology Industry Leader, - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive Officer - Yahoo Finance

Mar 20, 2025
pulisher
Mar 19, 2025

Interesting JAZZ Put And Call Options For October 17th - Nasdaq

Mar 19, 2025
pulisher
Mar 19, 2025

Does Jazz (JAZZ) Have the Potential to Rally 38.94% as Wall Street Analysts Expect? - Yahoo Finance

Mar 19, 2025
pulisher
Mar 19, 2025

Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting - PR Newswire

Mar 19, 2025
pulisher
Mar 17, 2025

Jazz Inks Insurer Class Deal As Xyrem Antitrust Trial Nears - Law360

Mar 17, 2025
pulisher
Mar 14, 2025

JAZZ or ILMN: Which Is the Better Value Stock Right Now? - Yahoo Finance

Mar 14, 2025
pulisher
Mar 14, 2025

Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition? - Yahoo Finance

Mar 14, 2025
pulisher
Mar 14, 2025

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock - Yahoo Finance

Mar 14, 2025
pulisher
Mar 12, 2025

Jazz Pharmaceuticals EVP sells shares worth $332,604 By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Jazz Pharmaceuticals and Boston Beer Company have been highlighted as Zacks Bull and Bear of the Day - Zacks Investment Research

Mar 12, 2025
pulisher
Mar 12, 2025

Bull of the Day: Jazz Pharmaceuticals (JAZZ) - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Insider Sell: Bruce Cozadd Sells 6,500 Shares of Jazz Pharmaceuticals PLC (JAZZ) - GuruFocus.com

Mar 12, 2025
pulisher
Mar 11, 2025

Bull Of The Day: Jazz Pharmaceuticals (JAZZ) - Barchart

Mar 11, 2025
pulisher
Mar 11, 2025

H.C. Wainwright lifts Jazz stock target to $217, maintains Buy By Investing.com - Investing.com UK

Mar 11, 2025
pulisher
Mar 11, 2025

Charles Schwab Investment Management Inc. Grows Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

HC Wainwright Issues Positive Forecast for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

DraftKings To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga India

Mar 10, 2025
pulisher
Mar 10, 2025

Victory Capital Management Inc. Increases Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Jazz Pharmaceuticals (NASDAQ:JAZZ) Upgraded at UBS Group - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Robert Iannone Sells 7,080 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Morgan Stanley Reiterates “Overweight” Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ) - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Truist Financial Boosts Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target to $230.00 - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

UBS Upgrades Jazz Pharmaceuticals (JAZZ) - Nasdaq

Mar 07, 2025
pulisher
Mar 07, 2025

Jazz Pharmaceuticals Plc to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Needham & Company LLC Reiterates Buy Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ) - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

UBS Upgrades Jazz Pharmaceuticals to Buy From Neutral, Adjusts Price Target to $179 From $145 - Marketscreener.com

Mar 07, 2025
pulisher
Mar 07, 2025

UBS raises Jazz Pharmaceuticals stock rating to Buy, target to $179 By Investing.com - Investing.com UK

Mar 07, 2025
pulisher
Mar 07, 2025

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals - Nasdaq

Mar 07, 2025

Jazz Pharmaceuticals Plc (JAZZ) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
大文字化:     |  ボリューム (24 時間):